Samjo Management LLC Sells 61,050 Shares of Aspen Aerogels, Inc. $ASPN

Key Points

• Samjo Management LLC sold 61,050 shares of Aspen Aerogels, reducing its stake by 7% to 813,600 shares, which represents 2.2% of its investment portfolio.
• Several major investors, including Vanguard Group Inc. and Millennium Management LLC, adjusted their holdings in Aspen Aerogels, indicating ongoing institutional interest.
• Aspen Aerogels' stock faces mixed analyst ratings, with a current consensus of "Moderate Buy" and a price target of $19.50, despite recent downgrades from firms like Oppenheimer and Barclays.

Samjo Management LLC lowered its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 7.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 813,600 shares of the construction company's stock after selling 61,050 shares during the period. Aspen Aerogels accounts for approximately 2.2% of Samjo Management LLC's holdings, making the stock its 13th biggest holding. Samjo Management LLC owned 0.99% of Aspen Aerogels worth $5,199,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Banque Cantonale Vaudoise purchased a new position in Aspen Aerogels during the first quarter valued at $45,000. Exchange Traded Concepts LLC increased its position in shares of Aspen Aerogels by 460.4% during the 1st quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock valued at $48,000 after purchasing an additional 6,109 shares during the last quarter. CWM LLC increased its position in shares of Aspen Aerogels by 2,137.9% during the 1st quarter. CWM LLC now owns 8,325 shares of the construction company's stock valued at $53,000 after purchasing an additional 7,953 shares during the last quarter. Teacher Retirement System of Texas purchased a new stake in shares of Aspen Aerogels during the 1st quarter valued at about $65,000. Finally, Sandia Investment Management LP purchased a new stake in shares of Aspen Aerogels during the 4th quarter valued at about $89,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Insiders Place Their Bets

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the firm's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the sale, the chief accounting officer owned 19,879 shares of the company's stock, valued at $145,315.49. This trade represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.30% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Barclays downgraded Aspen Aerogels from an "equal weight" rating to an "underweight" rating and upped their price target for the stock from $7.00 to $16.00 in a research note on Monday, August 11th. Finally, Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating on the stock in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $19.50.

Aspen Aerogels Trading Down 1.5%

ASPN traded down $0.11 during trading on Thursday, reaching $6.92. The company had a trading volume of 472,967 shares, compared to its average volume of 2,011,661. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The business has a 50 day simple moving average of $6.97 and a 200-day simple moving average of $6.70. Aspen Aerogels, Inc. has a 52 week low of $4.16 and a 52 week high of $30.24. The stock has a market cap of $569.52 million, a P/E ratio of -1.82 and a beta of 2.73.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.08. The firm had revenue of $78.02 million for the quarter, compared to analyst estimates of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The business's revenue for the quarter was down 33.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. On average, equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.